Physician profile
Andy Huang
NPI 1538632021
$5,028.93
in general payments reported to CMS, 2019-2025
19 companies · $1,509 in 2025
The $1,509 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $920 · 2023: $1,034 · 2024: $1,435 · 2025: $1,509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,977.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $653.28 | 2022-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $590.42 | 2023-2025 | Aveir |
| Bayer Healthcare Pharmaceuticals INC. | $547.80 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $546.17 | 2022-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $513.27 | 2022-2025 | Jardiance |
| Esperion Therapeutics, INC. | $444.98 | 2022-2024 | Nexletol, Nexlizet |
| Merck Sharp & Dohme LLC | $422.54 | 2023-2025 | Verquvo, Keytruda, Lynparza |
| Pfizer INC. | $267.70 | 2023-2025 | |
| Amgen INC. | $227.58 | 2022-2025 | Repatha, Repatha, Lumakras |
| Abiomed | $173.28 | 2025 | |
| Axsome Therapeutics, INC. | $120.75 | 2023 | Auvelity |
| Alnylam Pharmaceuticals INC. | $115.88 | 2025 | Amvuttra |
| Sanofi-Aventis U.S. LLC | $113.10 | 2022-2023 | |
| Abbvie INC. | $110.47 | 2021 | |
| Novo Nordisk INC | $77.28 | 2025 | Rybelsus, Ozempic |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $33.00 | 2024 | Amvia Edge |
| Medtronic, INC. | $31.02 | 2022 | |
| Sun Pharmaceutical Industries INC. | $20.97 | 2021 | |
| Boston Scientific Corporation | $19.44 | 2025 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andy Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.